Insulet (Nasdaq: PODD) saw its revenue increase 23% year-over-year to $488 million in the second quarter, which ended June 30. That’s according to preliminary Q2 revenue numbers that Insulet released today. The result beats the consensus of Wall Street analysts, who expected that Insulet had $460.27 million in revenue in Q2. The maker of Omnipod […]
Wall Street Beat
Dexcom stock falls on Q2 results that came up shy of ‘high standards’
Dexcom (Nasdaq:DXCM) (Nasdaq:DXCM) shares plummeted today on second-quarter results that came in mixed compared to the consensus forecast. Shares of DXCM fell more than 40% to $63.96 apiece in morning trading today. MassDevice‘s MedTech 100 Index was down slightly. The San Diego-based continuous glucose monitor (CGM) maker yesterday evening reported profits of $143.5 million. That […]
Embecta stock rises on reports that it might look to sell
Financial Times reports that Embecta (Nasdaq:EMBC), the former diabetes unit at BD, hired advisers to look into a possible sale of the company. Shares of EMBC ticked up 16.5% to $15.34 apiece in early-morning trading today. The company has operated as a standalone, publicly-traded company since April 2022, when it completed its spin-off from BD. […]
Surmodics to be acquired by private equity firm for $627M
Surmodics (Nasdaq:SRDX) announced today that it agreed to be acquired by GTCR, a private equity firm with healthcare interests. Eden Prairie, Minnesota-based Surmodics develops a range of technologies, including drug-coated balloons and thrombectomy systems. Its SurVeil DCB received a long-awaited FDA approval in June 2023. The company also reported successful early clinical use of its […]
Senseonics posts Q1 sales beat, submits 365-day iCGM to FDA
Senseonics (NYSE:SENS) shares ticked up after the market closed today on first-quarter results that came in ahead of the consensus sales forecast. Shares of SENS rose 8.1% to 41¢ apiece in post-market trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down slightly. […]
Insulet sales are up 23% but Q1 EPS misses Wall Street forecast
Insulet (Nasdaq:PODD) shares fell after hours today on first-quarter results that came in mixed compared to the consensus forecast. Shares of PODD dipped 3% to $172 apiece in after the market closed today. The Acton, Massachusetts-based automated insulin delivery technology developer reported profits of $51.5 million. That equals 73¢ per share on sales of $441.7 […]
Embecta stock skyrockets on Q1 beats, increased guidance as insulin pump tech progresses
Embecta (Nasdaq:EMBC) shares got a massive boost today on first-quarter results that came in well ahead of the consensus forecast. Shares of EMBC rose nearly 40% to $14.17 apiece in late-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 0.7%. The Parsippany-based BD diabetes […]
Tandem stock skyrockets on Q1 sales beat, increased pump shipments
Tandem Diabetes Care (Nasdaq:TNDM) shares got a massive boost today on first-quarter results that came in ahead of the consensus forecast. Shares of TNDM rose 26% to $46.08 in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. The San Diego-based automated insulin […]
Dexcom stock slides despite Q1 beats, sales guidance increase
Dexcom (Nasdaq:DXCM) shares took a hit after hours today on first-quarter results that came in ahead of the consensus forecast on Wall Street. Shares of DXCM dipped about 7% to $128.40 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the […]
FDA submission for 365-day CGM from Senseonics is ‘imminent’
Senseonics (NYSE:SENS) shares dipped after hours on fourth-quarter results that came in ahead of the consensus forecast. The company also reported an “imminent” submission of its latest, longest-lasting continuous glucose monitoring (CGM) technology. Shares of SENS fell 3.5% to 69¢ apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of […]
